Cargando…

Alternate Donor Transplantation

There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, William YK, Kongtim, Piyanuch, Majhail, Navneet S, Yao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200364/
https://www.ncbi.nlm.nih.gov/pubmed/37220609
http://dx.doi.org/10.31547/bct-2022-012
_version_ 1785045115725676544
author Hwang, William YK
Kongtim, Piyanuch
Majhail, Navneet S
Yao, Ming
author_facet Hwang, William YK
Kongtim, Piyanuch
Majhail, Navneet S
Yao, Ming
author_sort Hwang, William YK
collection PubMed
description There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and haploidentical transplantation can be carried out despite significant human leukocyte antigen (HLA) mismatches between patients and donors and help to meet this need. There are advantages and disadvantages to UCB and haploidentical transplantation, though enhancements in technology continue to improve outcomes in both. Donor selection for these cell sources is dependent on the presence of donor specific anti-HLA antibodies in the recipient's serum, degree and characteristics of donor-recipient HLA mismatches, ABO compatibility. Specific to haploidentical transplantation, additional factors like donor age, sex, donor-recipient CMV serology as well as NK cell alloreactivity are also important.
format Online
Article
Text
id pubmed-10200364
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Asia-Pacific Blood and Marrow Transplantation Group
record_format MEDLINE/PubMed
spelling pubmed-102003642023-05-22 Alternate Donor Transplantation Hwang, William YK Kongtim, Piyanuch Majhail, Navneet S Yao, Ming Blood Cell Ther State of the Art There is a significant need for alternative donors other than full-matched related or unrelated donors for allogeneic hematopoietic stem cell transplantation, especially in the Asia Pacific, where donor registries are smaller, and ethnicities are far more diverse. Both umbilical cord blood (UCB) and haploidentical transplantation can be carried out despite significant human leukocyte antigen (HLA) mismatches between patients and donors and help to meet this need. There are advantages and disadvantages to UCB and haploidentical transplantation, though enhancements in technology continue to improve outcomes in both. Donor selection for these cell sources is dependent on the presence of donor specific anti-HLA antibodies in the recipient's serum, degree and characteristics of donor-recipient HLA mismatches, ABO compatibility. Specific to haploidentical transplantation, additional factors like donor age, sex, donor-recipient CMV serology as well as NK cell alloreactivity are also important. Asia-Pacific Blood and Marrow Transplantation Group 2022-12-23 /pmc/articles/PMC10200364/ /pubmed/37220609 http://dx.doi.org/10.31547/bct-2022-012 Text en Copyright Ⓒ2022 Asia-Pacific Blood and Marrow Transplantation Group (APBMT). https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle State of the Art
Hwang, William YK
Kongtim, Piyanuch
Majhail, Navneet S
Yao, Ming
Alternate Donor Transplantation
title Alternate Donor Transplantation
title_full Alternate Donor Transplantation
title_fullStr Alternate Donor Transplantation
title_full_unstemmed Alternate Donor Transplantation
title_short Alternate Donor Transplantation
title_sort alternate donor transplantation
topic State of the Art
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200364/
https://www.ncbi.nlm.nih.gov/pubmed/37220609
http://dx.doi.org/10.31547/bct-2022-012
work_keys_str_mv AT hwangwilliamyk alternatedonortransplantation
AT kongtimpiyanuch alternatedonortransplantation
AT majhailnavneets alternatedonortransplantation
AT yaoming alternatedonortransplantation